The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and …

W Wu, Y Cheng, H Zhou, C Sun, S Zhang - Virology journal, 2023 - Springer
Abstract Coronavirus disease 2019 (COVID-19) continues to take a heavy toll on personal
health, healthcare systems, and economies around the globe. Scientists are expending …

Tartary buckwheat in human nutrition

Z Luthar, A Golob, M Germ, B Vombergar, I Kreft - Plants, 2021 - mdpi.com
Tartary buckwheat (Fagopyrum tataricum Gaertn.) originates in mountain areas of western
China, and it is mainly cultivated in China, Bhutan, northern India, Nepal, and central …

[HTML][HTML] Antibacterial Potential of Bacopa monnieri (L.) Wettst. and Its Bioactive Molecules against Uropathogens—An In Silico Study to Identify Potential Lead …

J Mehta, K Utkarsh, S Fuloria, T Singh, M Sekar… - Molecules, 2022 - mdpi.com
Urinary tract infections (UTIs) are becoming more common, requiring extensive protection
from antimicrobials. The global expansion of multi-drug resistance uropathogens in the past …

[HTML][HTML] Repurposing of phytomedicine-derived bioactive compounds with promising anti-SARS-CoV-2 potential: Molecular docking, MD simulation and drug-likeness …

M Rudrapal, N Gogoi, D Chetia, J Khan… - Saudi journal of …, 2022 - Elsevier
In view of the potential of traditional plant-based remedies (or phytomedicines) in the
management of COVID-19, the present investigation was aimed at finding novel anti-SARS …

Identification of DprE1 inhibitors for tuberculosis through integrated in-silico approaches

S Dash, E Rathi, A Kumar, K Chawla, SG Kini - Scientific Reports, 2024 - nature.com
Abstract Decaprenylphosphoryl-β-D-ribose-2′-epimerase (DprE1), a crucial enzyme in the
process of arabinogalactan and lipoarabinomannan biosynthesis, has become the target of …

In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2

M Rudrapal, AR Issahaku, C Agoni… - Journal of …, 2022 - Taylor & Francis
Due to the unavailability specific drugs or vaccines (FDA approved) that can cure COVID-19,
the development of potent antiviral drug candidates/therapeutic molecules against COVID …

Phytocompounds of Rheum emodi, Thymus serpyllum, and Artemisia annua Inhibit Spike Protein of SARS-CoV-2 Binding to ACE2 Receptor: In Silico Approach

R Rolta, D Salaria, PP Sharma, B Sharma… - Current pharmacology …, 2021 - Springer
COVID-19, the disease caused by SARS-CoV-2, has been declared as a global pandemic.
Traditional medicinal plants have long history to treat viral infections. Our in silico approach …

Assembly and entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2): evaluation using virus-like particles

B Kumar, GM Hawkins, T Kicmal, E Qing, E Timm… - Cells, 2021 - mdpi.com
Research on infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is
currently restricted to BSL-3 laboratories. SARS-CoV2 virus-like particles (VLPs) offer a BSL …

Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now

MA Mohammed - Frontiers in Pharmacology, 2023 - frontiersin.org
A novel coronavirus strain (COVID-19) caused severe illness and mortality worldwide from
31 December 2019 to 21 March 2023. As of this writing, 761,071,826 million cases have …

[HTML][HTML] An In Silico Investigation to Explore Anti-Cancer Potential of Foeniculum vulgare Mill. Phytoconstituents for the Management of Human Breast Cancer

B Kaur, R Rolta, D Salaria, B Kumar, OA Fadare… - Molecules, 2022 - mdpi.com
Breast cancer is one of the most prevalent cancers in the world. Traditionally, medicinal
plants have been used to cure various types of diseases and disorders. Based on a …